New treatment strategy aims to stop rare liver cancer
An OHSU surgeon’s innovative approach targets deadly cholangiocarcinoma of the liver. Jerry Widawski knew the statistics were not in his favor. At age 68, he was diagnosed with a rare...
Tag: pembrolizumab
Advancing immunotherapy for life-threatening prostate cancer
Restoring tumor-specific immunity is a treatment strategy that has worked well, but only against some cancers. Research led by OHSU oncologist Julie Graff, M.D., revived hope that the approach may...
These prostate cancer researchers are using gut bacteria to fight tumors
Cancer researchers at OHSU have been awarded $1 million to test the idea that adjusting the diversity of bacteria inhabiting the intestines could make aggressive prostate cancers more responsive to...
Immunotherapy takes a new turn for life-threatening prostate cancer
At the recent European Society for Medical Oncology meeting, OHSU oncologist Julie Graff, M.D., presented the first evidence of meaningful clinical activity for PD-1 blockade in men with...